SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
To donate by check, phone, or other method, see our More Ways to Give page.
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
The Oregon Democrat also informed colleagues of his staff's findings that "senators have been kept in the dark about executive branch surveillance of Senate phones," in apparent violation of companies' contracts.
U.S. Sen. Ron Wyden shared the results of his staff's probe into major phone companies in a Wednesday letter to congressional colleagues and also publicly highlighted which carriers disclose government spying to their customers.
"An investigation by my staff revealed that until recently, senators have been kept in the dark about executive branch surveillance of Senate phones, because the three major phone carriers—AT&T, Verizon, and T-Mobile—failed to establish systems to notify offices about surveillance requests, as required by their Senate contracts," states the letter, published on Wyden's (D-Ore.) congressional website.
"While now rectified for Senate-funded lines, significant gaps remain, especially for the campaign and personal phones used by most senators. I urge your support for legislative changes to allow the sergeant at arms (SAA) to protect senators' phones and accounts from cyber threats, both foreign and domestic," he wrote. "I also urge you to consider switching your campaign and personal phone lines to other carriers that will provide notice of government surveillance."
Wyden noted that "while AT&T and Verizon only provide notice of surveillance of phone lines paid for by the Senate, T-Mobile has informed my staff that it will provide notice for senators' campaign or personal lines flagged as such by the SAA. Three other carriers—Google Fi Wireless, U.S. Mobile, and Cape—have policies of notifying all customers about government demands whenever they are allowed to do so. The latter two companies adopted these policies after outreach from my office."
In a Wednesday statement announcing the letter and the above chart, Wyden's office warned that "beyond members of Congress, journalists, political activists, people seeking reproductive healthcare, and other law-abiding Americans who could be targeted by the government all have reason to be concerned about secret surveillance of their communications and location data."
The findings of his staff include details relevant to every American with a cellphone, but much of Wyden's letter is focused on improving protections for lawmakers. He pointed to "two troubling incidents" that "highlight the vulnerability of Senate communications" to foreign adversaries and U.S. law enforcement: Chinese Salt Typhoon hackers and the U.S. Department of Justice, during the first Trump administration, both collected records of lawmakers and their staff.
"Executive branch surveillance poses a significant threat to the Senate's independence and the foundational principle of separation of powers," Wyden argued. "If law enforcement officials, whether at the federal, state, or even local level, can secretly obtain senators' location data or call histories, our ability to perform our constitutional duties is severely threatened."
"This kind of unchecked surveillance can chill critical oversight activities, undermine confidential communications essential for legislative deliberations, and ultimately erode the legislative branch's co-equal status," he continued. Wyden called on senators to support his proposals for the next annual appropriations bill "that would allow the SAA to protect senators' phones and accounts—whether official, campaign, or personal—against cyber threats, just as we have for executive branch employees."
The longtime privacy advocate's letter to fellow senators was first reported by Politico, which noted that T-Mobile did not immediately respond to requests for comment while spokespeople for AT&T and Verizon defended their companies.
"We are complying with our obligations to the Senate sergeant at arms," AT&T spokesperson Alex Byers said in a statement to the outlet. "We have received no legal demands regarding Senate offices under the current contract, which began last June."
Verizon spokesperson Richard Young told Politico that "we respect the senator's view that providers should give notice to senators if we receive legal process regarding their use of their personal devices, but disagree with his policy position."
Meanwhile, Sean Vitka, executive director of Demand Progress—an advocacy group long critical of government spying on lawmakers and warrantless surveillance—said in response to the revelations from Wyden's office that "we now know that Comcast, Verizon, T-Mobile, and other phone companies have followed AT&T's unprecedented efforts to facilitate secret government surveillance of their own customers, with some even allowing the government to secretly spy on senators."
"This is a bright, red warning sign at a time when the Trump administration keeps blowing past constitutional checks on executive power and is siccing the Justice Department on elected lawmakers," Vitka added. "These companies should be shamed and ashamed until they fix this."
"If Trump is serious," said Sen. Bernie Sanders, "he will support legislation I will soon be introducing to make sure we pay no more for prescription drugs than people in other major countries."
If U.S. President Donald Trump actually wants to curb out-of-control prescription drug prices, he'll throw his support behind legislative efforts instead of trying to do so unilaterally—an approach that's unlikely to survive legal challenges.
That was the message that Sen. Bernie Sanders (I-Vt.) and congressional Democrats sent to the White House after Trump signed an executive order Monday aimed at pushing "pharmaceutical manufacturers to bring prices for American patients in line with comparably developed nations."
The order resembles an effort that a federal judge blocked during Trump's first term after the pharmaceutical industry mobilized against it.
Sanders, a longtime proponent of legislative action to address exorbitant medicine prices, said he agrees it is "an outrage that the American people pay, by far, the highest prices in the world for prescription drugs."
"As Trump well knows, his executive order will be thrown out by the courts," said Sanders. "If Trump is serious about making real change rather than just issuing a press release, he will support legislation I will soon be introducing to make sure we pay no more for prescription drugs than people in other major countries. If Republicans and Democrats come together on this legislation, we can get it passed in a few weeks."
If Trump is serious about making real change rather than just issuing a press release, he will support legislation I will introduce to ensure we pay no more for prescription drugs than people in other major countries. If we come together, we can get it passed in a few weeks.
[image or embed]
— Senator Bernie Sanders (@sanders.senate.gov) May 12, 2025 at 1:01 PM
Sanders and Rep. Ro Khanna (D-Calif.) have previously teamed up on a bill that would end drugmakers' monopoly control over a medication and allow generic competition if it is priced higher in the U.S. than in other rich nations.
An analysis released last year by the RAND Corporation estimated that prescription drug prices in the U.S. are, on average, 2.78 times higher than prices in Canada, Germany, France, and other comparable countries.
Khanna wrote on social media that he supports Trump's "effort to ensure Americans do not pay more for drugs than those in other countries." But, like Sanders, Khanna warned the executive order is likely doomed to fail.
"Instead of an EO that will get challenged again by Big Pharma, why not work with Bernie Sanders and me to make this law," the California Democrat wrote.
The pharmaceutical industry has made its opposition to Trump's latest order clear. In a statement, Pharmaceutical Research and Manufacturers of America CEO Stephen Ubl claimed that "importing foreign prices from socialist countries would be a bad deal for American patients and workers."
"It would mean less treatments and cures and would jeopardize the hundreds of billions our member companies are planning to invest in America," Ubl added, rehashing a common and false industry talking point.
"Donald Trump is all hat and no cattle when it comes to lowering the price of prescription drugs."
Since taking office, Trump has repeatedly claimed to support aggressive action to bring down drug prices while simultaneously working to roll back progress toward that goal. Last month, as Common Dreamsreported, Trump signed an executive order aimed at delaying Medicare price negotiations for a broad category of prescription drugs.
The price negotiations began during the Biden administration following Democratic lawmakers' passage of the Inflation Reduction Act, a law whose drug pricing provisions have so far withstood Big Pharma's legal onslaught.
Sen. Ron Wyden (D-Ore.) said in response to the president's executive order that "Donald Trump is all hat and no cattle when it comes to lowering the price of prescription drugs."
"Trump spent his entire first term blathering about Big Pharma, but in the end he always backed down instead of fighting for American seniors and families," said Wyden. "Democrats took on Big Pharma and won by finally giving Medicare the power to negotiate lower drug prices on behalf of seniors and capping their out-of-pocket costs for expensive prescriptions. If Trump was serious about lowering drug prices, he would work with Congress to strengthen Medicare drug price negotiations, not just sign a piece of paper."
"In any sane world, it would be a scandal that the vast majority of one political party would vote for a pointless tax on the American people, one that is hiking prices and destroying jobs, all to please one man."
Nearly every Senate Republican on Wednesday voted against a resolution aimed at terminating the national emergency that U.S. President Donald Trumpdeclared last month to impose his sweeping tariffs, which are wreaking economic havoc across the globe.
Just three Republicans—Sens. Lisa Murkowski (R-Alaska), Susan Collins (R-Maine), and Rand Paul (R-Ky.)—joined every voting Democrat in supporting the resolution led by Sen. Ron Wyden (D-Ore.). The measure deadlocked at 49 in favor and 49 against, and U.S. Vice President JD Vance subsequently cast a tie-breaking vote to table the resolution—which Trump had threatened to veto.
"In any sane world, it would be a scandal that the vast majority of one political party would vote for a pointless tax on the American people, one that is hiking prices and destroying jobs, all to please one man," Wyden said in a statement following the votes. "The only winner from Donald Trump's trade chaos is China, which is scooping up markets and trading partners that Trump has driven away. This vote represents a new low for the Republican Party."
Wyden said in a floor speech Wednesday that Trump's "senseless global tariffs" are "a major culprit" in the first U.S. economic contraction since 2022, as shown in a Bureau of Economic Analysis (BEA) report published earlier in the day.
"If this continues to be our tariff policy," the Oregon senator warned, "every major economist and forecaster is unfortunately predicting recession, job losses, and the misery that was all over our news feeds this morning."
Trump's tariffs currently stand at 10% on imports from most U.S. trading partners, and 145% on Chinese imports, as the White House negotiates bilateral deals behind closed doors.
Melinda St. Louis, Global Trade Watch director at Public Citizen, said Wednesday that "while strategic tariffs can be an important tool to support domestic manufacturing, Trump's inappropriate use of the International Emergency Economic Powers Act to push through sweeping and reckless tariffs actually has nothing to do with protecting U.S. workers."
"He's rolling back investments and support for domestic businesses and undermining workers' rights at home and likely pushing the agenda of Big Tech, Big Pharma, and other billionaire buddies in his secretive trade talks," St. Louis added.
The progressive advocacy group Americans for Tax Fairness (ATF) said Wednesday that Trump's tariffs have already hit U.S. households with a "$14 billion price hike," pointing to BEA data showing that "taxes on foreign imports spiked to $96.3 billion just in the first quarter of 2025, up $14 billion, or 17%, from the same period in 2024." Corporations often pass import tax costs to consumers in the form of price increases.
"Lower and middle-income households will bear a disproportionate share of the Trump Tariff Tax," ATF said. "While the bottom 60% of households take home roughly one-fifth of national income, they will pay nearly one-third of the price of Trump's tariff regime. Meanwhile, the top 1% highest-income households—those that take in over $940,000 a year—will pay only one-tenth of the Trump Tariff Tax, even though they get well over one-fifth of national income."
"This is all part of Trump and congressional Republicans' radical agenda to rig the tax code further in favor of the wealthy while sticking low- and middle-income families with the bill," the group added.